U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma

MedGen UID:
1717712
•Concept ID:
C5237040
•
Neoplastic Process

Definition

The reemergence of primary peritoneal high-grade serous adenocarcinoma after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Primary Peritoneal High Grade Serous Adenocarcinoma

Professional guidelines

PubMed

First-Line Management of Advanced High-Grade Serous Ovarian Cancer.
Mahmood RD, Morgan RD, Edmondson RJ, Clamp AR, Jayson GC
Curr Oncol Rep 2020 Jun 4;22(6):64. doi: 10.1007/s11912-020-00933-8. PMID: 32494876Free PMC Article
Does the method of primary treatment affect the pattern of first recurrence in high-grade serous ovarian cancer?
Himoto Y, Cybulska P, Shitano F, Sala E, Zheng J, Capanu M, Nougaret S, Nikolovski I, Vargas HA, Wang W, Mueller JJ, Chi DS, Lakhman Y
Gynecol Oncol 2019 Nov;155(2):192-200. Epub 2019 Sep 12 doi: 10.1016/j.ygyno.2019.08.011. PMID: 31521322Free PMC Article
A universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment.
Bednar EM, Oakley HD, Sun CC, Burke CC, Munsell MF, Westin SN, Lu KH
Gynecol Oncol 2017 Aug;146(2):399-404. Epub 2017 Jun 10 doi: 10.1016/j.ygyno.2017.05.037. PMID: 28610746Free PMC Article

Recent clinical studies

Etiology

Genomic catastrophe, the peritoneal cavity and ovarian cancer prevention.
Yoon JY, Chapel DB, Goebel E, Qian X, Mito JK, Horowitz NS, Miron A, Soong TR, Xian W, Crum CP
J Pathol 2022 Jul;257(3):255-261. Epub 2022 Apr 18 doi: 10.1002/path.5891. PMID: 35238033
Biomarkers expression among paired serous ovarian cancer primary lesions and their peritoneal cavity metastases in treatment-naïve patients: A single-center study.
Nikas IP, Lee C, Song MJ, Kim B, Ryu HS
Cancer Med 2022 Jun;11(11):2193-2203. Epub 2022 Feb 25 doi: 10.1002/cam4.4600. PMID: 35212471Free PMC Article
Artificial intelligence-based image analysis can predict outcome in high-grade serous carcinoma via histology alone.
Laury AR, Blom S, Ropponen T, Virtanen A, Carpén OM
Sci Rep 2021 Sep 27;11(1):19165. doi: 10.1038/s41598-021-98480-0. PMID: 34580357Free PMC Article
Prognostic significance of supraclavicular lymphadenopathy in patients with high-grade serous ovarian cancer.
Cybulska P, Hayes SA, Spirtos A, Rafizadeh MJ, Filippova OT, Leitao M, Zivanovic O, Sonoda Y, Mueller J, Lakhman Y, Long K, Chi DS
Int J Gynecol Cancer 2019 Nov;29(9):1377-1380. Epub 2019 Oct 1 doi: 10.1136/ijgc-2019-000829. PMID: 31575614Free PMC Article
Prognostic impact of intraoperative peritoneal cytology in interval debulking surgery for pelvic high-grade serous carcinoma.
Kojima N, Yoshida H, Kuno I, Uehara T, Uno M, Ishikawa M, Kato T
Cancer Med 2019 Aug;8(10):4598-4604. Epub 2019 Jun 26 doi: 10.1002/cam4.2377. PMID: 31243928Free PMC Article

Diagnosis

Artificial intelligence-based image analysis can predict outcome in high-grade serous carcinoma via histology alone.
Laury AR, Blom S, Ropponen T, Virtanen A, Carpén OM
Sci Rep 2021 Sep 27;11(1):19165. doi: 10.1038/s41598-021-98480-0. PMID: 34580357Free PMC Article
Primary mixed large cell neuroendocrine and high grade serous carcinoma of the endometrium.
Hardy LE, Chaudry Z, Wan K, Ayres C
BMJ Case Rep 2020 Sep 2;13(9) doi: 10.1136/bcr-2020-234977. PMID: 32878852Free PMC Article
Prognostic significance of supraclavicular lymphadenopathy in patients with high-grade serous ovarian cancer.
Cybulska P, Hayes SA, Spirtos A, Rafizadeh MJ, Filippova OT, Leitao M, Zivanovic O, Sonoda Y, Mueller J, Lakhman Y, Long K, Chi DS
Int J Gynecol Cancer 2019 Nov;29(9):1377-1380. Epub 2019 Oct 1 doi: 10.1136/ijgc-2019-000829. PMID: 31575614Free PMC Article
Prognostic impact of intraoperative peritoneal cytology in interval debulking surgery for pelvic high-grade serous carcinoma.
Kojima N, Yoshida H, Kuno I, Uehara T, Uno M, Ishikawa M, Kato T
Cancer Med 2019 Aug;8(10):4598-4604. Epub 2019 Jun 26 doi: 10.1002/cam4.2377. PMID: 31243928Free PMC Article
Characteristics of 10-year survivors of high-grade serous ovarian carcinoma.
Dao F, Schlappe BA, Tseng J, Lester J, Nick AM, Lutgendorf SK, McMeekin S, Coleman RL, Moore KN, Karlan BY, Sood AK, Levine DA
Gynecol Oncol 2016 May;141(2):260-263. Epub 2016 Mar 11 doi: 10.1016/j.ygyno.2016.03.010. PMID: 26968641Free PMC Article

Therapy

New therapeutic opportunities for women with low-grade serous ovarian cancer.
Moujaber T, Balleine RL, Gao B, Madsen I, Harnett PR, DeFazio A
Endocr Relat Cancer 2021 Nov 11;29(1):R1-R16. doi: 10.1530/ERC-21-0191. PMID: 34636747
Artificial intelligence-based image analysis can predict outcome in high-grade serous carcinoma via histology alone.
Laury AR, Blom S, Ropponen T, Virtanen A, Carpén OM
Sci Rep 2021 Sep 27;11(1):19165. doi: 10.1038/s41598-021-98480-0. PMID: 34580357Free PMC Article
First-Line Management of Advanced High-Grade Serous Ovarian Cancer.
Mahmood RD, Morgan RD, Edmondson RJ, Clamp AR, Jayson GC
Curr Oncol Rep 2020 Jun 4;22(6):64. doi: 10.1007/s11912-020-00933-8. PMID: 32494876Free PMC Article
Upfront debulking surgery versus interval debulking surgery for advanced tubo-ovarian high-grade serous carcinoma and diffuse peritoneal metastases treated with peritonectomy procedures plus HIPEC.
Biacchi D, Accarpio F, Ansaloni L, Macrì A, Ciardi A, Federici O, Spagnoli A, Cavaliere D, Vaira M, Sapienza P, Sammartino P
J Surg Oncol 2019 Dec;120(7):1208-1219. Epub 2019 Sep 17 doi: 10.1002/jso.25703. PMID: 31531879
Does the method of primary treatment affect the pattern of first recurrence in high-grade serous ovarian cancer?
Himoto Y, Cybulska P, Shitano F, Sala E, Zheng J, Capanu M, Nougaret S, Nikolovski I, Vargas HA, Wang W, Mueller JJ, Chi DS, Lakhman Y
Gynecol Oncol 2019 Nov;155(2):192-200. Epub 2019 Sep 12 doi: 10.1016/j.ygyno.2019.08.011. PMID: 31521322Free PMC Article

Prognosis

Biomarkers expression among paired serous ovarian cancer primary lesions and their peritoneal cavity metastases in treatment-naïve patients: A single-center study.
Nikas IP, Lee C, Song MJ, Kim B, Ryu HS
Cancer Med 2022 Jun;11(11):2193-2203. Epub 2022 Feb 25 doi: 10.1002/cam4.4600. PMID: 35212471Free PMC Article
New therapeutic opportunities for women with low-grade serous ovarian cancer.
Moujaber T, Balleine RL, Gao B, Madsen I, Harnett PR, DeFazio A
Endocr Relat Cancer 2021 Nov 11;29(1):R1-R16. doi: 10.1530/ERC-21-0191. PMID: 34636747
Artificial intelligence-based image analysis can predict outcome in high-grade serous carcinoma via histology alone.
Laury AR, Blom S, Ropponen T, Virtanen A, Carpén OM
Sci Rep 2021 Sep 27;11(1):19165. doi: 10.1038/s41598-021-98480-0. PMID: 34580357Free PMC Article
Prognostic significance of supraclavicular lymphadenopathy in patients with high-grade serous ovarian cancer.
Cybulska P, Hayes SA, Spirtos A, Rafizadeh MJ, Filippova OT, Leitao M, Zivanovic O, Sonoda Y, Mueller J, Lakhman Y, Long K, Chi DS
Int J Gynecol Cancer 2019 Nov;29(9):1377-1380. Epub 2019 Oct 1 doi: 10.1136/ijgc-2019-000829. PMID: 31575614Free PMC Article
Prognostic impact of intraoperative peritoneal cytology in interval debulking surgery for pelvic high-grade serous carcinoma.
Kojima N, Yoshida H, Kuno I, Uehara T, Uno M, Ishikawa M, Kato T
Cancer Med 2019 Aug;8(10):4598-4604. Epub 2019 Jun 26 doi: 10.1002/cam4.2377. PMID: 31243928Free PMC Article

Clinical prediction guides

Genomic catastrophe, the peritoneal cavity and ovarian cancer prevention.
Yoon JY, Chapel DB, Goebel E, Qian X, Mito JK, Horowitz NS, Miron A, Soong TR, Xian W, Crum CP
J Pathol 2022 Jul;257(3):255-261. Epub 2022 Apr 18 doi: 10.1002/path.5891. PMID: 35238033
Artificial intelligence-based image analysis can predict outcome in high-grade serous carcinoma via histology alone.
Laury AR, Blom S, Ropponen T, Virtanen A, Carpén OM
Sci Rep 2021 Sep 27;11(1):19165. doi: 10.1038/s41598-021-98480-0. PMID: 34580357Free PMC Article
Prognostic impact of intraoperative peritoneal cytology in interval debulking surgery for pelvic high-grade serous carcinoma.
Kojima N, Yoshida H, Kuno I, Uehara T, Uno M, Ishikawa M, Kato T
Cancer Med 2019 Aug;8(10):4598-4604. Epub 2019 Jun 26 doi: 10.1002/cam4.2377. PMID: 31243928Free PMC Article
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study.
Petrillo M, Marchetti C, De Leo R, Musella A, Capoluongo E, Paris I, Benedetti Panici P, Scambia G, Fagotti A
Am J Obstet Gynecol 2017 Sep;217(3):334.e1-334.e9. Epub 2017 May 23 doi: 10.1016/j.ajog.2017.05.036. PMID: 28549976
Metachronous serous endometrial intraepithelial carcinoma and serous peritoneal carcinoma: analysis of probable independent lesions.
Furuya M, Sato T, Tanaka R, Yamamoto M, Yokota NR, Miyagi E
Diagn Pathol 2016 Nov 14;11(1):130. doi: 10.1186/s13000-016-0585-0. PMID: 27842566Free PMC Article

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...